p_value_mlog	p_value	DgeneID	p_value_text	trait	intergenic	genes	OR_or_BETA	mapped_genes	context	initial_sample_description	UgeneID	identifier	risk_allele_freq	ACC	identifier	CHR_B_POS	contig_POS	CHR	FXN	MAF	allele	gene	organism	geneID
14.301029995663981	5.000000000000001E-15		(LSBMD)	Bone mineral density	0	IDUA	0.06	IDUA	missense_variant	Up to 32,961 European and East Asian ancestry individuals		rs3755955	0.16	NM_000203.4,NP_000194.2,NR_110313.1,NT_006051.19,XM_006713882.2,XM_011513459.1,XM_011513460.1,XM_011513461.1,XM_011513462.1,XM_011513463.1,XP_011511761.1,XP_011511762.1,XP_011511763.1,XR_924947.1	rs3755955		NT_006051.19:990626	4	missense,nc-transcript-variant,reference,utr-variant-5-prime	0.1687/845	B	IDUA	[Homo sapiens]	3425
5.301029995663981	4.9999999999999996E-6	105370834		Seasonality	0	GCOM2, POLR2M	0.59	GCOM1 - LOC105370834	intron_variant	3,269 European ancestry individuals	145781	rs1808478	NR	NM_001018090.6,NM_001018091.6,NM_001018102.2,NM_001285900.3,NM_015532.4,NR_104367.2,NR_104368.2,NR_104369.2,NR_104370.2,NR_104371.3,NT_010194.18	rs1808478		NT_010194.18:34440687	15	downstream-variant-500B	0.4437/2222	Y	GCOM1,POLR2M	[Homo sapiens]	145781,81488
21.30102999566398	5.0000000000000005E-22	105375344		Motion sickness	0	AUTS2	0.095	LOC105375343 - LOC105375344	intergenic_variant	80,494 European ancestry individuals	105375343	rs1195218	0.916	NT_007933.16	rs1195218		NT_007933.16:6652576	7		0.0266/133	Y		[Homo sapiens]	
5.522878745280337	3.0E-6	219699	(INS )	Obesity-related traits	0	PCBD1	0.04	LOC105378351 - UNC5B	intergenic_variant	815 Hispanic children from 263 families	105378351	rs1891159	0.491	NT_030059.14	rs1891159		NT_030059.14:29342599	10		0.3560/1783	R		[Homo sapiens]	
32.15490195998574	7.0E-33			QT interval	0	NOS1AP	2.19	NOS1AP	intron_variant	15,842 European ancestry individuals		rs4657178	0.33	NM_001164757.1,NM_014697.2,NT_004487.20	rs4657178		NT_004487.20:19056233	1	intron-variant	0.4002/2004	Y	NOS1AP	[Homo sapiens]	9722
9.0	1.0E-9			QT interval	0	NOS1AP	1.709	NOS1AP	intron_variant	6,805 Korean ancestry individuals		rs4657175	NR	NM_001164757.1,NM_014697.2,NT_004487.20	rs4657175		NT_004487.20:19041361	1	intron-variant	0.3299/1652	K	NOS1AP	[Homo sapiens]	9722
9.522878745280337	3.0E-10			QT interval	0	NOS1AP	1.9	NOS1AP	intron_variant	Up to 70,389 European ancestry individuals, up to 672 Orcadian individuals		rs17457880	0.055	NM_001164757.1,NM_014697.2,NT_004487.20	rs17457880		NT_004487.20:19013777	1	intron-variant	0.0108/54	R	NOS1AP	[Homo sapiens]	9722
8.0	1.0E-8			QT interval	0	NOS1AP	0.81	NOS1AP	intron_variant	Up to 70,389 European ancestry individuals, up to 672 Orcadian individuals		rs4657172	0.125	NM_001164757.1,NM_014697.2,NT_004487.20	rs4657172		NT_004487.20:19025255	1	intron-variant	0.1885/944	S	NOS1AP	[Homo sapiens]	9722
128.52287874528034	3.0E-129			QT interval	0	NOS1AP	2.74	NOS1AP	intron_variant	Up to 70,389 European ancestry individuals, up to 672 Orcadian individuals		rs3934467	0.222	NM_001164757.1,NM_014697.2,NT_004487.20	rs3934467		NT_004487.20:19028300	1	intron-variant	0.3259/1632	R	NOS1AP	[Homo sapiens]	9722
13.045757490560675	9.0E-14			QT interval	0	NOS1AP	1.78	NOS1AP	intron_variant	Up to 70,389 European ancestry individuals, up to 672 Orcadian individuals		rs7545047	0.049	NM_001164757.1,NM_014697.2,NT_004487.20	rs7545047		NT_004487.20:19036726	1	intron-variant	0.0180/90	R	NOS1AP	[Homo sapiens]	9722
37.0	1.0E-37			QT interval	0	NOS1AP	1.8	NOS1AP	intron_variant	Up to 70,389 European ancestry individuals, up to 672 Orcadian individuals		rs347272	0.132	NM_001164757.1,NM_014697.2,NT_004487.20	rs347272		NT_004487.20:19164121	1	intron-variant	0.1845/924	Y	NOS1AP	[Homo sapiens]	9722
7.698970004336019	2.0E-8		(females)	Body mass index (change over time)	0	NOS1AP	0.249	NOS1AP	intron_variant	2,643 Bangladeshi ancestry females, 2,340 Bangladeshi ancestry males		rs347313	0.322	NM_001164757.1,NM_014697.2,NT_004487.20	rs347313		NT_004487.20:19149899	1	intron-variant	0.3458/1732	R	NOS1AP	[Homo sapiens]	9722
5.301029995663981	4.9999999999999996E-6			Word reading	0	NOS1AP	0.123	NOS1AP	intron_variant	6,649 European ancestry children and adolescents		rs11577628	0.92	NM_001164757.1,NM_014697.2,NT_004487.20	rs11577628		NT_004487.20:19165147	1	intron-variant	0.0825/413	R	NOS1AP	[Homo sapiens]	9722
5.522878745280337	3.0E-6		(IGP2)	IgG glycosylation	0	NR	0.3771	SLC22A5	intron_variant	2,247 European ancestry individuals		rs7731390	0.947724237786775	NM_001308122.1,NM_003060.2,NM_003060.3,NT_034772.7,XM_005272055.2,XM_011543590.1,XR_427718.1,XR_948290.1,XR_948291.1	rs7731390		NT_034772.7:82276250	5	intron-variant	0.0110/55	S	SLC22A5	[Homo sapiens]	6584
5.698970004336019	2.0E-6		(IGP42)	IgG glycosylation	0	NR	0.3846	SLC22A5	intron_variant	2,247 European ancestry individuals		rs7731390	0.947771454651685	NM_001308122.1,NM_003060.2,NM_003060.3,NT_034772.7,XM_005272055.2,XM_011543590.1,XR_427718.1,XR_948290.1,XR_948291.1	rs7731390		NT_034772.7:82276250	5	intron-variant	0.0110/55	S	SLC22A5	[Homo sapiens]	6584
5.698970004336019	2.0E-6	64409	(remission - SSRI treated - 12 weeks)	Major depressive disorder	0	WBSCR17	1.7041	AUTS2 - WBSCR17	intergenic_variant	Up to 2,256 European ancestry cases	26053	rs1525293	0.66	NT_007933.16	rs1525293		NT_007933.16:8501240	7		0.3163/1584	Y		[Homo sapiens]	
5.698970004336019	2.0E-6	64409	(PC3)	Age-related hearing impairment	0	WBSCR17	0.1895	AUTS2 - WBSCR17	intergenic_variant	1,489 European ancestry individuals	26053	rs62459614		NT_007933.16	rs62459614		NT_007933.16:8615380	7		0.1585/794	Y		[Homo sapiens]	
8.0	1.0E-8	101927538		Mean corpuscular hemoglobin	0	C6orf182, CD164	0.111	CCDC162P - LOC101927538	intron_variant	Up to 14,362 Japanese ancestry individuals	221262	rs11966072	0.1	NT_025741.16	rs11966072		NT_025741.16:49083691	6		0.1671/837	R		[Homo sapiens]	
7.522878745280337	3.0000000000000004E-8	101927538		Mean corpuscular volume	0	C6orf182, CD164	0.11	CCDC162P - LOC101927538	intron_variant	14,364 Japanese ancestry individuals	221262	rs11966072	0.1	NT_025741.16	rs11966072		NT_025741.16:49083691	6		0.1671/837	R		[Homo sapiens]	
8.154901959985743	7.000000000000001E-9	101927538		Red blood cell count	0	C6orf182, CD164	0.114	CCDC162P - LOC101927538	intron_variant	14,392 Japanese ancestry individuals	221262	rs11966072	0.1	NT_025741.16	rs11966072		NT_025741.16:49083691	6		0.1671/837	R		[Homo sapiens]	
6.0	1.0E-6	79840		Height	0	IHH, CRYBA2, FEV, SLC23A3, TUBA1	6.9	IHH - NHEJ1	non_coding_transcript_exon_variant	30,968 European ancestry individuals	3549	rs1052483	0.91	NT_005403.18	rs1052483		NT_005403.18:124573611	2		0.1300/651	M		[Homo sapiens]	
7.0	1.0E-7			Chronic lymphocytic leukemia	0	FARP2	1.29	FARP2	missense_variant	2,179 European ancestry cases, 6,221 European ancestry controls		rs757978	0.11	NM_001282983.1,NM_001282984.1,NM_014808.3,NP_001269912.1,NP_001269913.1,NP_055623.1,NT_005403.18,XM_005247050.3,XM_011512233.1,XM_011512234.1,XM_011512235.1,XM_011512236.1,XM_011512237.1,XP_005247107.1,XP_011510535.1,XP_011510536.1,XP_011510537.1,XP_011510538.1,XP_011510539.1	rs757978		NT_005403.18:146935671	2	missense,reference	0.0805/403	D	FARP2	[Homo sapiens]	9855
8.698970004336019	2.0E-9		(EA)	Fibrinogen	0	FARP2	0.007	FARP2	intron_variant	91,323 European ancestry individuals		rs1476698	0.65	NM_001282983.1,NM_001282984.1,NM_014808.3,NT_005403.18,XM_005247050.3,XM_011512233.1	rs1476698		NT_005403.18:146861019	2	intron-variant	0.4700/2354	Y	FARP2	[Homo sapiens]	9855
11.522878745280337	3.0E-12			Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	0	CYP3A5	0.495	CYP3A7-CYP3A51P, ZSCAN25	intron_variant	1,794 European ancestry cases, 18 African and Asian ancestry cases		rs188845491	0.007	NM_001256497.2,NT_007933.16,XR_927402.1	rs188845491		NT_007933.16:37182237	7	intron-variant	0.0004/2	Y	CYP3A7-CYP3A51P,ZSCAN25	[Homo sapiens]	100861540,221785
5.301029995663981	4.9999999999999996E-6		(SM vs. Control)	Bipolar disorder	0	AUTS2	1.775	AUTS2	intron_variant	2,191 European ancestry cases, 1,434 European ancestry controls		rs10237317	NR	NM_001127231.2,NM_015570.3,NT_007933.16,XM_011516010.1,XM_011516011.1,XM_011516012.1,XM_011516013.1,XM_011516014.1,XM_011516015.1,XM_011516016.1,XM_011516017.1,XM_011516018.1	rs10237317		NT_007933.16:8074176	7	intron-variant	0.4954/2481	R	AUTS2	[Homo sapiens]	26053
7.3979400086720375	4.0E-8		(quantile transformation)	Alcohol consumption	0	AUTS2	0.013	AUTS2	intron_variant	26,316 European ancestry individuals		rs6943555	0.24	NM_001127231.2,NM_015570.3,NT_007933.16,XM_011516010.1,XM_011516011.1,XM_011516012.1,XM_011516013.1,XM_011516014.1,XM_011516015.1,XM_011516016.1,XM_011516017.1,XM_011516018.1	rs6943555		NT_007933.16:7834258	7	intron-variant	0.3748/1877	W	AUTS2	[Homo sapiens]	26053
6.3979400086720375	4.0E-7		(Arm span )	Obesity-related traits	0	AUTS2	0.04	AUTS2	intron_variant	815 Hispanic children from 263 families		rs11766624	0.153	NM_001127231.2,NM_015570.3,NT_007933.16,XM_011516010.1,XM_011516011.1,XM_011516012.1,XM_011516013.1,XM_011516014.1,XM_011516015.1,XM_011516016.1,XM_011516017.1,XM_011516018.1	rs11766624		NT_007933.16:7915320	7	intron-variant	0.1747/875	R	AUTS2	[Homo sapiens]	26053
5.221848749616356	6.0E-6		(EA, women)	Body mass index	0	AUTS2	0.021	AUTS2	intron_variant	up to 104,666 European ancestry male individuals, up to 132,115 European ancestry female individuals, 370 African American male individuals, 517 African American female individuals, 512 Hispanic male individuals, 764 Hispanic female individuals		rs38313	0.505	NM_001127231.2,NM_015570.3,NT_007933.16,XM_011516010.1,XM_011516011.1,XM_011516012.1,XM_011516013.1,XM_011516014.1,XM_011516015.1,XM_011516016.1,XM_011516017.1,XM_011516018.1	rs38313		NT_007933.16:8095914	7	intron-variant	0.3401/1703	Y	AUTS2	[Homo sapiens]	26053
8.301029995663981	5.0E-9			Prostate cancer	0	BOK-AS1, DTYMK, FARP2, HDLBP, SEP2, STK25, THAP4, ANO7, ATG4B, BOK	1.12	FARP2	3_prime_UTR_variant	11,085 European ancestry cases, 11,463 European ancestry controls		rs3771570	0.15	NM_001282983.1,NM_001282984.1,NM_014808.3,NT_005403.18,XM_005247050.3,XM_011512233.1,XM_011512234.1,XM_011512235.1,XM_011512236.1,XM_011512237.1	rs3771570		NT_005403.18:146947434	2	intron-variant	0.0911/456	Y	FARP2	[Homo sapiens]	9855
13.045757490560675	9.0E-14			Height	0	MAP3K3	0.036	MAP3K3, LOC101927898	intron_variant	36,227 East Asian ancestry individuals		rs3785574	0.46	NM_002401.3,NM_203351.1,NT_010783.16,XM_005257376.2,XM_005257377.2,XM_005257378.2,XR_243740.2,XR_934463.1	rs3785574		NT_010783.16:36749845	17	intron-variant	0.3377/1691	R	LOC101927898,MAP3K3	[Homo sapiens]	101927898,4215
5.301029995663981	4.9999999999999996E-6			Manganese levels	1	WNK1	0.909			949 European ancestry individuals		chr12:1019300		NM_001033604.1,NM_001033605.1,NM_014451.3,NM_198428.2,NT_007819.18,XM_005249700.3,XM_005249701.1,XM_011515264.1,XM_011515265.1,XM_011515266.1,XM_011515267.1,XM_011515268.1,XM_011515269.1,XM_011515270.1	rs12		NT_007819.18:33223336	7	intron-variant	0.2115/1059	W	BBS9	[Homo sapiens]	27241
8.522878745280337	3.0000000000000004E-9			PR interval	0	ARHGAP24	2.28	ARHGAP24	intron_variant	13,415 African American individuals		rs11732231	0.23	NM_001025616.2,NT_016354.20,XM_005263263.3	rs11732231		NT_016354.20:26841026	4	intron-variant	0.2784/1394	B	ARHGAP24	[Homo sapiens]	83478
16.522878745280337	3.0E-17		(PR interval)	Electrocardiographic traits	0	ARHGAP24	8.46	ARHGAP24	intron_variant	Up to 12,670 European ancestry individuals		rs7660702	0.74	NM_001025616.2,NT_016354.20,XM_005263263.3	rs7660702		NT_016354.20:26808930	4	intron-variant	0.3890/1948	Y	ARHGAP24	[Homo sapiens]	83478
19.221848749616356	5.999999999999999E-20			PR interval	0	ARHGAP24	2.01	ARHGAP24	intron_variant	28,517 European ancestry individuals		rs7692808	0.31	NM_001025616.2,NT_016354.20,XM_005263263.3	rs7692808		NT_016354.20:26798615	4	intron-variant	0.3241/1623	R	ARHGAP24	[Homo sapiens]	83478
5.301029995663981	4.9999999999999996E-6		(Amylin )	Obesity-related traits	0	ARHGAP24	0.03	ARHGAP24	intron_variant	815 Hispanic children from 263 families		rs7687906	0.217	NM_001025616.2,NM_001042669.1,NT_016354.20,XM_005263263.3	rs7687906		NT_016354.20:26872778	4	intron-variant	0.1861/932	K	ARHGAP24	[Homo sapiens]	83478
14.0	1.0E-14			PR segment	0	ARHGAP24	1.764	ARHGAP24	intron_variant	16,468 European ancestry individuals		rs13137008	0.697	NM_001025616.2,NT_016354.20,XM_005263263.3	rs13137008		NT_016354.20:26831665	4	intron-variant	0.3349/1677	K	ARHGAP24	[Homo sapiens]	83478
8.0	1.0E-8	196872		HDL cholesterol	0	ZBTB42, AKT1	0.02	ZBTB42 - LINC00638	downstream_gene_variant	94,595 European ancestry individuals	100128927	rs4983559	0.4	NT_026437.13	rs4983559		NT_026437.13:86587349	14		0.4046/2026	R		[Homo sapiens]	
5.301029995663981	4.9999999999999996E-6		(Harm avoidance)	Temperament	0	SLA, TG	0.32	TG, SLA	intron_variant	Up to 12,433 European ancestry individuals		rs2741200	0.671	NM_001045556.2,NM_001045557.2,NM_001282964.1,NM_001282965.1,NM_003235.4,NM_006748.3,NT_008046.17,XM_005251038.3,XM_006716622.2,XM_011517227.1	rs2741200		NT_008046.17:47345366	8	intron-variant	0.3391/1698	Y	SLA,TG	[Homo sapiens]	6503,7038
5.698970004336019	2.0E-6		(HOMA-IR)	Obesity-related traits	0	PCBD1, SLC29A3	0.03	SLC29A3	synonymous_variant	815 Hispanic children from 263 families		rs1084004	0.377	NM_001174098.1,NM_018344.5,NP_060814.4,NR_033413.1,NR_033414.1,NT_030059.14,XM_006717910.2,XP_006717973.1	rs1084004		NT_030059.14:29668667	10	nc-transcript-variant,reference,synonymous-codon,utr-variant-3-prime	0.2462/1233	Y	SLC29A3	[Homo sapiens]	55315
8.096910013008056	8.0E-9			Graves' disease	0	SLA, WISP1, TG	1.16	TG	intron_variant	1,442 Han Chinese ancestry cases, 1,468 Han Chinese ancestry controls		rs2294025	0.19	NM_003235.4,NT_008046.17,XM_005251038.3,XM_006716622.2	rs2294025		NT_008046.17:47419046	8	intron-variant	0.3936/1971	R	TG	[Homo sapiens]	7038
5.154901959985743	7.0E-6			Classic bladder exstrophy	0	NR	7.44	CCDC15	intron_variant	208 European ancestry cases, 1,703 European ancestry controls		rs76239813	0.016	NM_025004.2,NT_033899.9	rs76239813		NT_033899.9:37036790	11	intron-variant	0.0130/65	W	CCDC15	[Homo sapiens]	80071
7.0	1.0E-7	153020	(Pubertal growth)	Pubertal anthropometrics	0	BMP3, PRKG2	0.08	PRKG2 - RASGEF1B	intergenic_variant	up to 5,043 European ancestry males, up to 5,756 European ancestry females	5593	rs1662853	0.76	NT_016354.20	rs1662853		NT_016354.20:22302391	4		0.3572/1789	S		[Homo sapiens]	
8.397940008672037	4.0E-9	3111		Asthma	0	HLA-DOA	1.13	BRD2 - HLA-DOA	intergenic_variant	1,532 Japanese ancestry cases, 3,304 Japanese ancestry controls	6046	rs9500927	0.26	NT_007592.16,NT_113891.3,NT_167245.2,NT_167246.2,NT_167248.2,NT_167249.2	rs9500927		NT_007592.16:32933584|NT_113891.3:4405781|NT_167245.2:4237119|NT_167246.2:4412961|NT_167248.2:4187905|NT_167249.2:4442825	6		0.2013/1008	R		[Homo sapiens]	
5.221848749616356	6.0E-6		(SF7)	Response to amphetamines	0	CNTLN		CNTLN	intron_variant	1 American Indian ancestry individual, 18 African American individuals, 10 Asian ancestry individuals, 325 European ancestry individuals, 17 Hispanic individuals, 10 individuals		rs10810790	NR	NM_017738.3,NT_008413.19,XM_005251492.1,XM_006716793.2,XM_011517940.1,XM_011517942.1	rs10810790		NT_008413.19:17448874	9	intron-variant	0.2776/1390	Y	CNTLN	[Homo sapiens]	54875
9.698970004336019	2.0E-10	9242	(EA, women)	Waist-to-hip ratio adjusted for body mass index	0	MSC	0.0329	LOC105375892 - MSC	intergenic_variant	up to 56,910 European ancestry men, up to 86,570 European ancestry women	105375892	rs12679556	0.2477	NT_008183.20	rs12679556		NT_008183.20:25674728	8		0.4465/2236	K		[Homo sapiens]	
10.698970004336019	2.0E-11	9242	(EA)	Waist-to-hip ratio adjusted for body mass index	0	MSC	0.0268	LOC105375892 - MSC	intergenic_variant	up to 56,910 European ancestry men, up to 86,570 European ancestry women	105375892	rs12679556	0.2475	NT_008183.20	rs12679556		NT_008183.20:25674728	8		0.4465/2236	K		[Homo sapiens]	
9.522878745280337	3.0E-10	9242	(women)	Waist-to-hip ratio adjusted for body mass index	0	MSC	0.0316	LOC105375892 - MSC	intergenic_variant	up to 56,910 European ancestry men, up to 86,570 European ancestry women	105375892	rs12679556	0.2711	NT_008183.20	rs12679556		NT_008183.20:25674728	8		0.4465/2236	K		[Homo sapiens]	
9.698970004336019	2.0E-10	9242		Waist-to-hip ratio adjusted for body mass index	0	MSC	0.0243	LOC105375892 - MSC	intergenic_variant	up to 56,910 European ancestry men, up to 86,570 European ancestry women	105375892	rs12679556	0.2767	NT_008183.20	rs12679556		NT_008183.20:25674728	8		0.4465/2236	K		[Homo sapiens]	
20.0	1.0E-20			Crohn's disease	0	IL3, IRF1, SLC22A5, SLC22A4	1.23	C5orf56	intron_variant	6,333 European ancestry cases, 15,056 European ancestry controls		rs12521868	0.422	NR_045116.1,NT_034772.7	rs12521868		NT_034772.7:82338894	5	intron-variant	0.1382/692	K	C5orf56	[Homo sapiens]	441108
5.3979400086720375	4.0E-6			Height	0	PPIL6, SMPD2, MNICAL1, ZBTB24, CD164	4.7	PPIL6	intron_variant	30,968 European ancestry individuals		rs9487094	0.69	NM_001111298.2,NM_001286360.1,NM_001286361.1,NM_173672.4,NR_104429.1,NT_025741.16,XM_011535764.1,XM_011535765.1,XM_011535766.1,XM_011535767.1,XM_011535768.1,XM_011535769.1	rs9487094		NT_025741.16:49190878	6	intron-variant	0.4832/2420	R	PPIL6	[Homo sapiens]	285755
5.096910013008056	8.0E-6		(phenotype 2)	Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	0	NR	1.64	FAM167A	intron_variant	Up to 737 European ancestry individuals, Up to 545 Black individuals, Up to 314 Hispanic individuals		rs17742757	NR	NT_077531.5,XM_011543840.1	rs17742757		NT_077531.5:3805705	8	intron-variant	0.4912/2460	Y	FAM167A	[Homo sapiens]	83648
5.698970004336019	2.0E-6	153020		Height	0	BMP3, PRKG2, RASGEF1B	5.0	PRKG2 - RASGEF1B	intergenic_variant	30,968 European ancestry individuals	5593	rs710841	0.27	NT_016354.20	rs710841		NT_016354.20:22307296	4		0.3564/1785	R		[Homo sapiens]	
6.0	1.0E-6			Breast size	0	SLC4A1AP, GCKR	0.08	SNX17	intron_variant	16,175 European ancestry female individuals		rs4665972	0.448	NM_001267059.1,NM_001267060.1,NM_001267061.1,NM_014748.3,NR_049782.1,NR_049783.1,NR_049784.1,NR_049785.1,NR_049786.1,NR_049787.1,NR_049788.1,NT_022184.16,XM_011533203.1	rs4665972		NT_022184.16:11229111	2	intron-variant	0.2815/1410	Y	SNX17	[Homo sapiens]	9784
5.522878745280337	3.0E-6			Amyotrophic lateral sclerosis (sporadic)	1	MSC				250 Han Chinese ancestry cases, 250 Han Chinese ancestry controls		kgp692907		NT_016354.20,XR_939347.1	rs692907		NT_016354.20:92970494	4	intron-variant	0.1795/899	Y	LOC102724700	[Homo sapiens]	102724700
5.522878745280337	3.0E-6		(Height z-score )	Obesity-related traits	0	CYP2E1	0.03	CYP2E1	intron_variant	815 Hispanic children from 263 families		rs2249694	0.225	NM_000773.3,NT_030059.14	rs2249694		NT_030059.14:91845128	10	intron-variant	0.4459/2233	R	CYP2E1	[Homo sapiens]	1571
5.698970004336019	2.0E-6	57604	(Vegetable)	Colorectal cancer (diet interaction)	0	KIAA1456, LONRF1	1.64	LOC105379289 - KIAA1456	intergenic_variant	9,287 European ancestry cases, 9,117 European ancestry controls	105379289	rs6989010	0.98-0.99	NT_167187.2	rs6989010		NT_167187.2:630901	8		0.0329/165	K		[Homo sapiens]	
52.0	1.0E-52			Inflammatory bowel disease	0	CSF2, IL13, IL4, IL5, IL3, IRF1, SLC22A5, ACSL6, PDLIM4, SLC22A4	1.158	C5orf56	intron_variant	12,924 European ancestry cases, 21,442 European ancestry controls		rs2188962	0.425	NR_045116.1,NT_034772.7	rs2188962		NT_034772.7:82325306	5	intron-variant	0.1382/692	Y	C5orf56	[Homo sapiens]	441108
18.30102999566398	5.0E-19	105375983		Ovarian cancer	0	BNC2, LOC648570, CNTLN	1.22	BNC2 - LOC105375983	intergenic_variant	1,817 European ancestry cases, 2,353 European ancestry controls	54796	rs3814113	0.68	NT_008413.19	rs3814113		NT_008413.19:16905023	9		0.4439/2223	Y		[Homo sapiens]	
6.0	1.0E-6			Fibrinogen	0	IRF1, SLC22A5, SLC22A4	9.51	LOC553103, SLC22A4	synonymous_variant	17,686 European ancestry female individuals		rs10479002	0.04	NM_003059.2,NP_003050.2,NR_110997.1,NT_034772.7,XM_006714675.2,XM_011543589.1,XP_006714738.1,XP_011541891.1	rs10479002		NT_034772.7:82226162	5	intron-variant,reference,synonymous-codon	0.0184/92	S	LOC553103,SLC22A4	has merged	553103,6583
10.0	1.0E-10			QT interval	0	NOS1AP		LOC105371475, NOS1AP	intron_variant	100 European ancestry > 445ms female individuals, 100 European ancestry < 386ms female individuals		rs10494366		NM_001164757.1,NM_014697.2,NT_004487.20,XR_922217.1,XR_922219.1,XR_922221.1	rs10494366		NT_004487.20:18931308	1	intron-variant	0.4157/2082	K	LOC105371475,NOS1AP	[Homo sapiens]	105371475,9722
9.154901959985743	7.000000000000001E-10		(QTc interval)	Electrocardiographic traits	0	NOS1AP	2.53	LOC105371475, NOS1AP	intron_variant	6,543 Indian Asian ancestry individuals		rs1415259	0.39	NM_001164757.1,NM_014697.2,NT_004487.20,XR_922217.1,XR_922219.1,XR_922221.1	rs1415259		NT_004487.20:18930932	1	intron-variant	0.4157/2082	R	LOC105371475,NOS1AP	[Homo sapiens]	105371475,9722
21.30102999566398	5.0000000000000005E-22		(QT interval)	Electrocardiographic traits	0	NOS1AP	12.2	LOC105371475, NOS1AP	intron_variant	Up to 12,670 European ancestry individuals		rs10494366	0.39	NM_001164757.1,NM_014697.2,NT_004487.20,XR_922217.1,XR_922219.1,XR_922221.1	rs10494366		NT_004487.20:18931308	1	intron-variant	0.4157/2082	K	LOC105371475,NOS1AP	[Homo sapiens]	105371475,9722
83.0	1.0E-83	9722		QT interval	0	NOS1AP, OLFML2B	0.18	OLFML2B - NOS1AP	intergenic_variant	3,558 European ancestry individuals	25903	rs12143842	0.25	NT_004487.20	rs12143842		NT_004487.20:18879513	1		0.2688/1346	Y		[Homo sapiens]	
5.698970004336019	2.0E-6			Disc degeneration (lumbar)	0	PFKP	0.17	PFKP	intron_variant	4,683 European ancestry individuals		rs7896691	0.10	NM_001242339.1,NM_002627.4,NT_008705.17,XM_005252465.3,XM_005252466.3,XM_005252467.2,XM_006717449.1	rs7896691		NT_008705.17:3102981	10	intron-variant	0.1260/631	Y	PFKP	[Homo sapiens]	5214
12.0	1.0E-12	441108		Fibrinogen	0	IRF1, SLC22A5, SLC22A4	6.84	SLC22A5 - C5orf56	upstream_gene_variant	17,686 European ancestry female individuals	6584	rs1016988	0.20	NR_045116.1,NT_034772.7	rs1016988		NT_034772.7:82299075	5	upstream-variant-2KB	0.2448/1226	Y	C5orf56	[Homo sapiens]	441108
57.69897000433602	2.0E-58			Chronic hepatitis C infection	0	ITPA		ITPA	missense_variant	988 European ancestry cases, 198 African American cases, 100 Hispanic cases		rs1127354	0.069	NM_001267623.1,NM_033453.3,NM_181493.2,NP_258412.1,NP_852470.1,NR_052000.1,NR_052001.1,NR_052002.1,NT_011387.9,XM_006723564.2,XM_006723565.2,XM_011529234.1,XM_011529235.1,XP_006723627.1,XP_011527536.1,XP_011527537.1	rs1127354		NT_011387.9:3153196	20	intron-variant,missense,nc-transcript-variant,reference	0.0895/448	N	ITPA	[Homo sapiens]	3704
75.04575749056067	8.999999999999999E-76			Chronic hepatitis C infection	0	ITPA		ITPA	intron_variant	988 European ancestry cases, 198 African American cases, 100 Hispanic cases		rs7270101	0.11	NM_001267623.1,NM_033453.3,NM_181493.2,NR_052000.1,NR_052001.1,NR_052002.1,NT_011387.9,XM_006723564.2,XM_006723565.2,XM_011529234.1,XM_011529235.1	rs7270101		NT_011387.9:3153247	20	intron-variant	0.0591/296	M	ITPA	[Homo sapiens]	3704
9.522878745280337	3.0E-10			Migraine without aura	0	TSC1, TBC1D7, PHACTR1	1.16	PHACTR1	intron_variant	7,107 European ancestry cases, 69,427 European ancestry controls		rs9349379	0.6	NM_001242648.1,NM_030948.2,NT_007592.16,XM_005248933.1,XM_005248934.1,XM_005248935.3,XM_011514390.1	rs9349379		NT_007592.16:12843725	6	intron-variant	0.3774/1890	R	PHACTR1	[Homo sapiens]	221692
5.221848749616356	6.0E-6		(EA, men)	Body mass index	0	WNK1	0.024	WNK1	intron_variant	up to 104,666 European ancestry male individuals, up to 132,115 European ancestry female individuals, 370 African American male individuals, 517 African American female individuals, 512 Hispanic male individuals, 764 Hispanic female individuals		rs11611246	0.203	NM_001184985.1,NM_014823.2,NM_018979.3,NM_213655.4,NT_009759.17,XM_006719003.1,XM_011520997.1,XM_011520998.1,XM_011520999.1,XM_011521000.1,XM_011521001.1,XM_011521002.1,XM_011521003.1,XM_011521004.1,XM_011521006.1,XM_011521007.1,XM_011521008.1,XM_011521009.1	rs11611246		NT_009759.17:820314	12	intron-variant	0.2057/1030	K	WNK1	[Homo sapiens]	65125
6.698970004336019	2.0E-7		(EA)	Body mass index	0	WNK1	0.021	WNK1	intron_variant	up to 104,666 European ancestry male individuals, up to 132,115 European ancestry female individuals, 370 African American male individuals, 517 African American female individuals, 512 Hispanic male individuals, 764 Hispanic female individuals		rs11611246	0.202	NM_001184985.1,NM_014823.2,NM_018979.3,NM_213655.4,NT_009759.17,XM_006719003.1,XM_011520997.1,XM_011520998.1,XM_011520999.1,XM_011521000.1,XM_011521001.1,XM_011521002.1,XM_011521003.1,XM_011521004.1,XM_011521006.1,XM_011521007.1,XM_011521008.1,XM_011521009.1	rs11611246		NT_009759.17:820314	12	intron-variant	0.2057/1030	K	WNK1	[Homo sapiens]	65125
6.698970004336019	2.0E-7			Body mass index	0	WNK1	0.02	WNK1	intron_variant	up to 104,666 European ancestry male individuals, up to 132,115 European ancestry female individuals, 370 African American male individuals, 517 African American female individuals, 512 Hispanic male individuals, 764 Hispanic female individuals		rs11611246	0.201	NM_001184985.1,NM_014823.2,NM_018979.3,NM_213655.4,NT_009759.17,XM_006719003.1,XM_011520997.1,XM_011520998.1,XM_011520999.1,XM_011521000.1,XM_011521001.1,XM_011521002.1,XM_011521003.1,XM_011521004.1,XM_011521006.1,XM_011521007.1,XM_011521008.1,XM_011521009.1	rs11611246		NT_009759.17:820314	12	intron-variant	0.2057/1030	K	WNK1	[Homo sapiens]	65125
9.221848749616356	6.0E-10			Height	0	MAP3K3	0.053	LOC101927898, MAP3K3	intron_variant	20,427 African ancestry individuals		rs11658329	0.70	NM_002401.3,NM_203351.1,NT_010783.16,XM_005257376.2,XM_005257377.2,XM_005257378.2,XR_243740.2,XR_934463.1	rs11658329		NT_010783.16:36749691	17	intron-variant	0.3359/1682	S	LOC101927898,MAP3K3	[Homo sapiens]	101927898,4215
9.301029995663981	5.0E-10			Height	0	MAP3K3	0.049	LOC101927898, MAP3K3	intron_variant	8,149 African American female individuals		rs11658329	0.30	NM_002401.3,NM_203351.1,NT_010783.16,XM_005257376.2,XM_005257377.2,XM_005257378.2,XR_243740.2,XR_934463.1	rs11658329		NT_010783.16:36749691	17	intron-variant	0.3359/1682	S	LOC101927898,MAP3K3	[Homo sapiens]	101927898,4215
50.0	1.0E-50	283652		Skin pigmentation	0	SLC24A5	12.5	LOC102724553 - SLC24A5	intergenic_variant	363 South Asian ancestry low maxL* individuals, 374 South Asian ancestry high maxL* individuals	102724553	rs1834640	0.08	NT_010194.18	rs1834640		NT_010194.18:24823094	15		0.4633/2320	R		[Homo sapiens]	
8.698970004336019	2.0E-9			Motion sickness	0	AUTS2	0.033	LOC105375347, AUTS2	intron_variant	80,494 European ancestry individuals		rs6946969	0.658	NM_001127231.2,NM_015570.3,NT_007933.16,XM_011516010.1,XM_011516011.1,XM_011516012.1,XM_011516013.1,XM_011516014.1,XM_011516015.1,XM_011516016.1,XM_011516017.1,XM_011516018.1,XR_927653.1	rs6946969		NT_007933.16:8239262	7	intron-variant,nc-transcript-variant	0.3926/1966	R	LOC105375347,AUTS2	[Homo sapiens]	105375347,26053
6.096910013008056	8.0E-7			Copper levels	1	FARP2	0.421			949 European ancestry individuals		chr2:242387786		NM_001160139.1,NM_001310477.1,NM_023872.3,NT_039169.8,XM_006495500.1	rs2		NT_039169.8:18958803	1	intron-variant		R	Kcnq5	[]	226922
11.301029995663981	5.0E-12	105374342	(FNK)	Bone mineral density	0	FGFRL1		IDUA - LOC105374342	upstream_gene_variant	5,833 European ancestry females, 2,639 European ancestry males, 784 Han Chinese ancestry females, 763 Han Chinese ancestry males, 712 African American females, 409 Hispanic females	3425	rs6827815	NR	NT_006051.19,XR_925036.1	rs6827815		NT_006051.19:995657	4	upstream-variant-2KB	0.2294/1149	S	LOC105374342	[Homo sapiens]	105374342
9.0	1.0E-9		(ER -ve)	Breast cancer (survival)	0	HEPACAM, HEPN1, CCDC15, SLC37A2, TMEM218, FEZ1, MGC39545, STT3A, CHEK1, ACRV1, PATE1, PATE2, PATE3, PATE4, HYLS1, PKNOX2, ROBO4	1.9	PKNOX2	intron_variant	23,059 European ancestry estrogen-receptor positive cases, 6,881 European ancestry estrogen-receptor negative cases, 8,014 European ancestry cases		rs2059614	0.06	NM_022062.2,NT_033899.9,XM_005271642.1,XM_005271643.1,XM_006718894.1,XM_011542944.1,XM_011542945.1,XM_011542946.1,XM_011542947.1	rs2059614		NT_033899.9:37386632	11	intron-variant	0.0403/202	Y	PKNOX2	[Homo sapiens]	63876
8.698970004336019	2.0E-9			Male-pattern baldness	0	AUTS2	1.27	LOC105375343	intergenic_variant	3,891 European ancestry cases, 8,915 European ancestry controls		rs6945541	0.539	NT_007933.16,XR_927647.1	rs6945541		NT_007933.16:6640194	7	intron-variant	0.2071/1037	Y	LOC105375343	[Homo sapiens]	105375343
5.154901959985743	7.0E-6		(IGP15)	IgG glycosylation	0	NR	0.1881	ARHGAP24	intergenic_variant	2,247 European ancestry individuals		rs7691216	0.155663414959929	NT_016354.20,XM_005263263.3	rs7691216		NT_016354.20:26287082	4	intron-variant	0.2813/1409	K	ARHGAP24	[Homo sapiens]	83478
7.698970004336019	2.0E-8			Vitiligo	0	SLA	1.2	TG	intron_variant	418 European ancestry cases, 2,810 European ancestry controls		rs853308	0.48	NM_003235.4,NT_008046.17,XM_005251038.3,XM_005251040.3,XM_005251042.3,XM_005251043.3,XM_006716622.2	rs853308		NT_008046.17:47203450	8	intron-variant	0.3526/1766	R	TG	[Homo sapiens]	7038
5.522878745280337	3.0E-6		(Adiponectin)	Protein quantitative trait loci	0	DUT		DUT	intron_variant	1,200 European ancestry individuals		rs11637235	0.28	NM_001025248.1,NM_001025249.1,NM_001948.3,NT_010194.18,XM_011521315.1,XR_931760.1	rs11637235		NT_010194.18:25064082	15	intron-variant	0.3379/1692	Y	DUT	[Homo sapiens]	1854
5.221848749616356	6.0E-6			Amyotrophic lateral sclerosis (sporadic)	0	PDGFRL		PDGFRL	intron_variant	250 Han Chinese ancestry cases, 250 Han Chinese ancestry controls		rs13256095		NM_006207.2,NT_167187.2,XM_011544558.1	rs13256095		NT_167187.2:5319567	8	intron-variant	0.0801/401	K	PDGFRL	[Homo sapiens]	5157
5.698970004336019	2.0E-6			Alzheimer's disease	0	SLC4A1AP	2.05	SLC4A1AP	intron_variant	513 African American cases, 496 African American controls		rs17006206	0.10	NM_018158.2,NT_022184.16	rs17006206		NT_022184.16:11538487	2	intron-variant	0.0319/160	R	SLC4A1AP	[Homo sapiens]	22950
11.045757490560675	9.0E-12	3549		Height	0	CCDC108/IHH	0.041	CCDC108 - IHH	upstream_gene_variant	133,653 European ancestry individuals	255101	rs12470505	0.9	NT_005403.18	rs12470505		NT_005403.18:124547632	2		0.1931/967	K		[Homo sapiens]	
8.221848749616356	6.000000000000001E-9	640		Rheumatoid arthritis	0	BLK	1.19	FAM167A - BLK	intergenic_variant	2,418 European ancestry cases, 4,504 European ancestry controls	83648	rs2736340	0.24	NT_077531.5	rs2736340		NT_077531.5:3819337	8		0.3614/1810	Y		[Homo sapiens]	
9.698970004336019	2.0E-10	640		Systemic lupus erythematosus	0	BLK	1.391	FAM167A - BLK	upstream_gene_variant	1,527 European ancestry cases, 3,421 European ancestry controls,	83648	rs13277113	NR	NT_077531.5	rs13277113		NT_077531.5:3824550	8		0.3576/1791	R		[Homo sapiens]	
12.698970004336019	2.0E-13	640		Systemic lupus erythematosus	0	BLK	1.4925	FAM167A - BLK	intergenic_variant	1,656 Han Chinese ancestry cases, 3,394 Han Chinese ancestry controls	83648	rs2254546	0.73	NT_077531.5	rs2254546		NT_077531.5:3819044	8		0.1597/800	R		[Homo sapiens]	
6.522878745280337	3.0E-7	640	(anti-dsDNA +)	Systemic lupus erythematosus	0	BLK	1.38	FAM167A - BLK	intergenic_variant	811 anti-dsDNA positive European ancestry cases, 906 anti-dsDNA negative European ancestry cases, 4,813 European ancestry controls	83648	rs2736340	0.23	NT_077531.5	rs2736340		NT_077531.5:3819337	8		0.3614/1810	Y		[Homo sapiens]	
9.045757490560675	9.0E-10	640		Kawasaki disease	0	BLK	1.538	FAM167A - BLK	intergenic_variant	622 Han Chinese ancestry cases, 1,107 Han Chinese ancestry controls	83648	rs2736340	0.722	NT_077531.5	rs2736340		NT_077531.5:3819337	8		0.3614/1810	Y		[Homo sapiens]	
23.69897000433602	2.0E-24	640		Systemic lupus erythematosus	0	BLK	1.45	FAM167A - BLK	intergenic_variant	1,047 Han Chinese ancestry cases, 1,205 Han Chinese ancestry controls	83648	rs7812879	0.76	NT_077531.5	rs7812879		NT_077531.5:3815545	8		0.1845/924	Y		[Homo sapiens]	
8.0	1.0E-8	640		Systemic lupus erythematosus and Systemic sclerosis	0	BLK	1.217	FAM167A - BLK	intergenic_variant	up to 2,761 European ancestry systemic sclerosis cases, 769 European ancestry systemic lupus erythematosus cases, 7,381 European ancestry controls	83648	rs2736340	NR	NT_077531.5	rs2736340		NT_077531.5:3819337	8		0.3614/1810	Y		[Homo sapiens]	
12.522878745280337	3.0000000000000003E-13	640		Rheumatoid arthritis	0	BLK	1.11	FAM167A - BLK	regulatory_region_variant	up to 14,361 European ancestry cases, up to 42,923 European ancestry controls, up to 4,873 East Asian ancestry cases, up to 17,642 East Asian ancestry controls	83648	rs2736337	0.36	NT_077531.5	rs2736337		NT_077531.5:3817244	8		0.3730/1868	Y		[Homo sapiens]	
7.096910013008056	8.0E-8	640	(EA)	Rheumatoid arthritis	0	BLK	1.09	FAM167A - BLK	regulatory_region_variant	up to 14,361 European ancestry cases, up to 42,923 European ancestry controls, up to 4,873 East Asian ancestry cases, up to 17,642 East Asian ancestry controls	83648	rs2736337	0.25	NT_077531.5	rs2736337		NT_077531.5:3817244	8		0.3730/1868	Y		[Homo sapiens]	
6.698970004336019	2.0E-7	640	(East Asian)	Rheumatoid arthritis	0	BLK	1.15	FAM167A - BLK	regulatory_region_variant	up to 14,361 European ancestry cases, up to 42,923 European ancestry controls, up to 4,873 East Asian ancestry cases, up to 17,642 East Asian ancestry controls	83648	rs2736337	0.67	NT_077531.5	rs2736337		NT_077531.5:3817244	8		0.3730/1868	Y		[Homo sapiens]	
5.698970004336019	2.0E-6			Aging (time to death)	0	BIN2	0.09	BIN2	intron_variant	25,007 European ancestry individuals		rs766903	0.83	NM_001290007.1,NM_001290008.1,NM_001290009.1,NM_016293.3,NT_029419.13,XM_005268957.2,XM_005268958.2,XM_011538452.1	rs766903		NT_029419.13:14074798	12	intron-variant	0.2079/1041	Y	BIN2	[Homo sapiens]	51411
5.3979400086720375	4.0E-6			Myopia (pathological)	0	GATA4		GATA4	intron_variant	187 European ancestry cases, 1064 European ancestry controls		rs804280	0.406	NM_001308093.1,NM_001308094.1,NM_002052.4,NT_077531.5,XM_005272384.1,XM_005272385.3,XM_005272386.1,XM_006716248.1,XM_006716249.2,XM_011543817.1,XM_011543818.1	rs804280		NT_077531.5:4088062	8	intron-variant	0.2656/1330	K	GATA4	[Homo sapiens]	2626
6.0	1.0E-6		(men)	Urate levels in obese individuals	0	MPP6, DFNA5	0.119	MPP6	intron_variant	4,613 European ancestry male individuals, 4,690 European ancestry female individuals, 142 European ancestry individuals		rs2529049	0.76	NM_001303037.1,NM_016447.3,NT_007819.18,XM_005249775.3,XM_006715738.2,XM_006715739.2,XM_006715740.2,XM_011515425.1	rs2529049		NT_007819.18:24669987	7	intron-variant	0.4385/2196	Y	MPP6	[Homo sapiens]	51678
27.045757490560675	9.0E-28	153020		Height	0	PRKG2/BMP3	0.043	PRKG2 - RASGEF1B	intergenic_variant	133,653 European ancestry individuals	5593	rs788867	0.68	NT_016354.20	rs788867		NT_016354.20:22307471	4		0.3716/1861	M		[Homo sapiens]	
14.522878745280337	3.0000000000000002E-15	153020		Height	0	RASGEF1B	0.046	PRKG2 - RASGEF1B	intergenic_variant	36,227 East Asian ancestry individuals	5593	rs2011962	0.82	NT_016354.20	rs2011962		NT_016354.20:22377789	4		0.3832/1919	K		[Homo sapiens]	
9.096910013008056	8.0E-10	153020		Height	0	intergenic	0.054	PRKG2 - RASGEF1B	intergenic_variant	20,427 African ancestry individuals	5593	rs994014	0.29	NT_016354.20	rs994014		NT_016354.20:22323255	4		0.3906/1956	R		[Homo sapiens]	
8.698970004336019	2.0E-9	105376352		Amyotrophic lateral sclerosis (sporadic)	0	PFKP	3.1004	LOC105376350 - LOC105376352	intergenic_variant	250 Han Chinese ancestry cases, 250 Han Chinese ancestry controls	105376350	rs9329300	0.19	NT_008705.17	rs9329300		NT_008705.17:2737402	10		0.1146/574	M		[Homo sapiens]	
6.154901959985743	7.0E-7			Height	0	MAP3K3, WDR68, LYK5, MT1F	4.8	MAP3K3	intron_variant	30,968 European ancestry individuals		rs7209435	0.27	NM_002401.3,NM_203351.1,NT_010783.16,XM_005257376.2,XM_005257377.2,XM_005257378.2,XR_934463.1	rs7209435		NT_010783.16:36699624	17	intron-variant	0.3383/1694	Y	MAP3K3	[Homo sapiens]	4215
6.3979400086720375	4.0E-7	392193	(Retinal venular caliber)	Retinal vascular caliber	0	XKR6, SOX7, GATA4, MTMR9, PINX1	1.0	XKR6 - RPL19P13	downstream_gene_variant	15,358 European ancestry individuals	286046	rs7824557	0.39	NT_077531.5	rs7824557		NT_077531.5:3579475	8		0.3195/1600	R		[Homo sapiens]	
5.3979400086720375	4.0E-6			Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	0	NR		PDGFRL	intron_variant	207 Brazilian ancestry cases, 306 Brazilian ancestry controls		rs7829987	NR	NM_006207.2,NT_167187.2,XM_011544558.1	rs7829987		NT_167187.2:5320368	8	intron-variant	0.1168/585	K	PDGFRL	[Homo sapiens]	5157
5.522878745280337	3.0E-6		(East Asian)	Colorectal cancer	0	NR	1.11	WNK1	intron_variant	2,098 East Asian ancestry cases, 6,172 East Asian ancestry controls		rs12309274	0.85	NM_001184985.1,NM_014823.2,NM_018979.3,NM_213655.4,NT_009759.17,XM_006719003.1,XM_011520997.1,XM_011520998.1,XM_011520999.1,XM_011521000.1,XM_011521001.1,XM_011521002.1,XM_011521003.1,XM_011521004.1,XM_011521005.1,XM_011521006.1,XM_011521007.1,XM_011521008.1,XM_011521009.1	rs12309274		NT_009759.17:856782	12	intron-variant	0.1577/790	K	WNK1	[Homo sapiens]	65125
6.0	1.0E-6			Diisocyanate-induced asthma	0	ARHGAP24, C4orf12, MAPK10	34.08	ARHGAP24	intron_variant	74 European ancestry cases, 824 European ancestry controls		rs16995986	0.001	NM_001025616.2,NT_016354.20,XM_005263263.3	rs16995986		NT_016354.20:26850783	4	intron-variant	0.0593/297	R	ARHGAP24	[Homo sapiens]	83478
5.096910013008056	8.0E-6	1854		Metabolite levels (Pyroglutamine)	0	SLC12A1	0.15	SLC12A1 - DUT	downstream_gene_variant	1,260 African American individuals	6557	rs964611		NT_010194.18	rs964611		NT_010194.18:25028443	15		0.1476/739	K		[Homo sapiens]	
9.397940008672037	4.0E-10			Mean corpuscular volume	0	CD164	0.0	CCDC162P	intron_variant	24,167 European ancestry individuals		rs9374080	NR	NR_028595.1,NT_025741.16	rs9374080		NT_025741.16:49065283	6	intron-variant	0.2740/1372	Y	CCDC162P	[Homo sapiens]	221262
44.52287874528034	3.0E-45			QT interval	0	NOS1AP	2.98	NOS1AP, LOC105371475	intron_variant	13,685 European ancestry individuals		rs12029454	0.15	NM_001164757.1,NM_014697.2,NT_004487.20,XR_922217.1,XR_922218.1,XR_922219.1,XR_922220.1,XR_922221.1,XR_922222.1	rs12029454		NT_004487.20:18978740	1	intron-variant	0.2931/1468	R	LOC105371475,NOS1AP	[Homo sapiens]	105371475,9722
34.0	1.0E-34			QT interval	0	NOS1AP	2.63	NOS1AP, LOC105371475	intron_variant	13,685 European ancestry individuals		rs16857031	0.14	NM_001164757.1,NM_014697.2,NT_004487.20,XR_922217.1,XR_922219.1,XR_922221.1	rs16857031		NT_004487.20:18958533	1	intron-variant	0.1893/948	S	LOC105371475,NOS1AP	[Homo sapiens]	105371475,9722
5.045757490560675	9.0E-6		(Hip circumference )	Obesity-related traits	0	NOS1AP	0.03	NOS1AP, LOC105371475	intron_variant	815 Hispanic children from 263 families		rs76662883	0.0060	NM_001164757.1,NM_014697.2,NT_004487.20,XR_922217.1,XR_922219.1,XR_922221.1	rs76662883		NT_004487.20:18934941	1	intron-variant	0.0036/18	V	LOC105371475,NOS1AP	[Homo sapiens]	105371475,9722
60.15490195998574	7.0E-61			QT interval	0	NOS1AP	2.37	NOS1AP, LOC105371475	intron_variant	Up to 70,389 European ancestry individuals, up to 672 Orcadian individuals		rs16857031	0.132	NM_001164757.1,NM_014697.2,NT_004487.20,XR_922217.1,XR_922219.1,XR_922221.1	rs16857031		NT_004487.20:18958533	1	intron-variant	0.1893/948	S	LOC105371475,NOS1AP	[Homo sapiens]	105371475,9722
15.522878745280337	3.0E-16			QT interval	0	NOS1AP	4.6	NOS1AP, LOC105371474	intron_variant	Up to 70,389 European ancestry individuals, up to 672 Orcadian individuals		rs17460657	0.045	NM_001164757.1,NM_014697.2,NT_004487.20,XR_922215.1	rs17460657		NT_004487.20:19107449	1	intron-variant	0.0164/82	M	LOC105371474,NOS1AP	[Homo sapiens]	105371474,9722
7.698970004336019	2.0E-8	153020		Height	0	PRKG2	0.07	PRKG2 - RASGEF1B	intergenic_variant	12,611 European ancestry individuals	5593	rs710841	0.12	NT_016354.20	rs710841		NT_016354.20:22307296	4		0.3564/1785	R		[Homo sapiens]	
17.397940008672037	4.0E-18	153020		Height	0	PRKG2	1.2	PRKG2 - RASGEF1B	intergenic_variant	8,097 European ancestry tall individuals, 8,099 European ancestry short individuals	5593	rs1878528	0.33	NT_016354.20	rs1878528		NT_016354.20:22341699	4		0.3460/1733	Y		[Homo sapiens]	
47.096910013008056	8.0E-48	153020		Height	0	PRKG2	0.046	PRKG2 - RASGEF1B	intergenic_variant	253,288 European ancestry individuals	5593	rs17556750	0.314	NT_016354.20	rs17556750		NT_016354.20:22313033	4		0.1707/855	M		[Homo sapiens]	
77.69897000433602	2.0E-78	9722		QT interval	0	NOS1AP	3.15	OLFML2B - NOS1AP	intergenic_variant	13,685 European ancestry individuals	25903	rs12143842	0.26	NT_004487.20	rs12143842		NT_004487.20:18879513	1		0.2688/1346	Y		[Homo sapiens]	
77.69897000433602	2.0E-78	9722		QT interval	0	NOS1AP	2.88	OLFML2B - NOS1AP	intergenic_variant	15,842 European ancestry individuals	25903	rs12143842	0.24	NT_004487.20	rs12143842		NT_004487.20:18879513	1		0.2688/1346	Y		[Homo sapiens]	
14.698970004336019	2.0E-15	9722		QT interval	0	NOS1AP	3.14	OLFML2B - NOS1AP	intergenic_variant	13,105 African American individuals	25903	rs12143842	0.80	NT_004487.20	rs12143842		NT_004487.20:18879513	1		0.2688/1346	Y		[Homo sapiens]	
9.698970004336019	2.0E-10	9722		QT interval	0	NOS1AP	0.19	OLFML2B - NOS1AP	intergenic_variant	2,325 European ancestry individuals	25903	rs2880058	0.32	NT_004487.20	rs2880058		NT_004487.20:18860255	1		0.3828/1917	R		[Homo sapiens]	
213.0	1.0E-213	9722		QT interval	0	NOS1AP	3.5	OLFML2B - NOS1AP	intergenic_variant	Up to 70,389 European ancestry individuals, up to 672 Orcadian individuals	25903	rs12143842	0.24	NT_004487.20	rs12143842		NT_004487.20:18879513	1		0.2688/1346	Y		[Homo sapiens]	
17.397940008672037	4.0E-18	9722	(QT)	Electrocardiographic traits	0	NOS1AP	3.888	OLFML2B - NOS1AP	intergenic_variant	2,994 Japnese ancestry individuals	25903	rs12143842	0.39	NT_004487.20	rs12143842		NT_004487.20:18879513	1		0.2688/1346	Y		[Homo sapiens]	
30.096910013008056	8.0E-31		(Systolic)	Blood pressure	0	RPL6, ALDH2, PTPN11	1.56	HECTD4	intron_variant	19,608 East Asian ancestry individuals		rs11066280	0.75	NM_001109662.3,NT_029419.13	rs11066280		NT_029419.13:75144727	12	intron-variant	0.0449/225	W	HECTD4	[Homo sapiens]	283450
35.0	1.0E-35		(Diastolic)	Blood pressure	0	RPL6, ALDH2, PTPN11	1.01	HECTD4	intron_variant	19,608 East Asian ancestry individuals		rs11066280	0.75	NM_001109662.3,NT_029419.13	rs11066280		NT_029419.13:75144727	12	intron-variant	0.0449/225	W	HECTD4	[Homo sapiens]	283450
5.698970004336019	2.0E-6	374977		Non-substance related behavioral disinhibition	0	GLIS1	1.752	ACOT11 - MROH7	upstream_gene_variant	7,188 European ancestry individuals	26027	rs1368882	0.379	NM_001039464.3,NM_001291332.1,NR_026782.2,NR_037639.2,NR_037640.2,NR_037641.2,NR_111931.1,NT_032977.10	rs1368882		NT_032977.10:54055358	1	upstream-variant-2KB	0.3976/1991	Y	MROH7-TTC4,MROH7	[Homo sapiens]	100527960,374977
14.154901959985743	7.0E-15			Retinol levels	0	RBP4	0.03	FFAR4	3_prime_UTR_variant	5,006 European ancestry individuals		rs10882272	0.35	NM_001195755.1,NM_181745.3,NT_030059.14	rs10882272		NT_030059.14:51894904	10	utr-variant-3-prime	0.3898/1952	Y	FFAR4	[Homo sapiens]	338557
10.698970004336019	2.0E-11			Dehydroepiandrosterone sulphate levels	0	TRIM4, CYP3A43	0.11	TRIM4	3_prime_UTR_variant	14,846 European ancestry individuals		rs17277546	0.05	NM_033017.3,NM_033091.2,NT_007933.16	rs17277546		NT_007933.16:37385169	7	utr-variant-3-prime	0.0170/85	R	TRIM4	[Homo sapiens]	89122
28.397940008672037	4.0E-29	441108	(tryptophan betaine )	Blood metabolite levels	0	SLC22A4	0.126	SLC22A5 - C5orf56	upstream_gene_variant	7,824 European ancestry individuals	6584	rs2405522	0.17	NT_034772.7	rs2405522		NT_034772.7:82296197	5		0.2867/1436	R		[Homo sapiens]	
49.30102999566398	5.0E-50		(X12063 levels)	Blood metabolite levels	0	NR		CYP3A5, ZSCAN25	intron_variant	3,953 European ancestry individuals		rs4646450	NR	NM_000777.4,NM_001291829.1,NM_001291830.1,NR_033807.2,NT_007933.16,XM_006715859.2,XM_011515843.1,XM_011515844.1,XM_011515845.1,XM_011515846.1,XM_011515847.1,XM_011515909.1,XR_927383.1,XR_927402.1	rs4646450		NT_007933.16:37161916	7	intron-variant	0.4671/2339	Y	CYP3A5,ZSCAN25	[Homo sapiens]	1577,221785
108.69897000433602	2.0E-109		(X-12063)	Blood metabolite levels	0	CYP3A5	0.221	ZSCAN25	upstream_gene_variant	7,824 European ancestry individuals		rs10242455	0.93	NT_007933.16,XM_011515909.1,XM_011515910.1,XR_927402.1	rs10242455		NT_007933.16:37135777	7	intron-variant	0.3906/1956	R	ZSCAN25	[Homo sapiens]	221785
8.301029995663981	5.0E-9		(citrate)	Blood metabolite levels	0	SLC13A5	0.025	FBXO39	missense_variant	7,824 European ancestry individuals		rs1509123	0.05	NM_153230.2,NP_694962.1,NT_010718.17,XM_011523697.1,XP_011521999.1,XR_243544.3	rs1509123		NT_010718.17:6291572	17	missense,nc-transcript-variant,reference	0.0300/150	D	FBXO39	[Homo sapiens]	162517
5.698970004336019	2.0E-6	100270950	(quantitative)	Emphysema-related traits	0	CDH6	1.83	LOC102723637 - RPL19P11	intergenic_variant	2,383 European ancestry cases	102723637	rs9292394	0.78	NT_006576.17	rs9292394		NT_006576.17:30651466	5		0.3239/1622	K		[Homo sapiens]	
9.0	1.0E-9	100270950		Liver enzyme levels (gamma-glutamyl transferase)	0	CDH6	2.7	LOC102723637 - RPL19P11	intergenic_variant	Up to 52,350 European ancestry individuals, up to 8,739 Indian Asian ancestry individuals	102723637	rs6888304	0.74	NT_006576.17	rs6888304		NT_006576.17:31010414	5		0.2594/1299	R		[Homo sapiens]	
6.221848749616356	6.0E-7	100270950	(PhysVAS)	Response to methotrexate in juvenile idiopathic arthritis	0	CDH6	1.45	LOC102723637 - RPL19P11	intergenic_variant	694 European ancestry child cases	102723637	rs12652364	NR	NT_006576.17	rs12652364		NT_006576.17:30825972	5		0.1412/707	R		[Homo sapiens]	
9.0	1.0E-9		(IFN-related thrombocytopenia at wk 4)	IFN-related cytopenia	0	ITPA		C20orf194	intron_variant	984 European ancestry with genotype 1 HCV cases, 201 African American genotype 1 HCV cases, 99 Hispanic genotype 1 HCV cases		rs965469	NR	NM_001009984.2,NT_011387.9,XM_005260684.2,XM_005260686.2,XM_006723556.2	rs965469		NT_011387.9:3340902	20	intron-variant	0.1853/928	Y	C20orf194	[Homo sapiens]	25943
10.522878745280337	3.0E-11			QT interval	0	NOS1AP	0.72	SH2D1B	intron_variant	Up to 70,389 European ancestry individuals, up to 672 Orcadian individuals		rs164133	0.264	NM_053282.4,NT_004487.20	rs164133		NT_004487.20:19226911	1	intron-variant	0.3271/1638	S	SH2D1B	[Homo sapiens]	117157
7.221848749616356	6.000000000000001E-8			Bladder cancer	0	SLC14A2	1.13	LOC105372093, SLC14A1	intron_variant	up to 2,305 European ancestry cases, up to 3,901 European ancestry controls		rs10775480	0.43	NM_001128588.3,NM_001146036.2,NM_001146037.1,NM_001308278.1,NM_001308279.1,NM_015865.6,NT_010966.15,XM_005258329.1,XM_005258332.1,XM_005258333.1,XM_006722526.2,XM_011526141.1,XM_011526142.1,XM_011526143.1,XM_011526144.1,XR_935425.1	rs10775480		NT_010966.15:24826111	18	intron-variant	0.2901/1453	Y	LOC105372093,SLC14A1	[Homo sapiens]	105372093,6563
8.045757490560675	9.000000000000001E-9			Bladder cancer	0	SLC14A1	1.2	SLC14A1, LOC105372093	intron_variant	4,501 European ancestry cases, 6,076 European ancestry controls		rs7238033		NM_001128588.3,NM_001146036.2,NM_001146037.1,NM_001308278.1,NM_001308279.1,NM_015865.6,NT_010966.15,XM_005258329.1,XM_005258332.1,XM_005258333.1,XM_006722526.2,XM_011526141.1,XM_011526142.1,XM_011526143.1,XM_011526144.1,XR_935425.1	rs7238033		NT_010966.15:24825795	18	intron-variant	0.2901/1453	Y	LOC105372093,SLC14A1	[Homo sapiens]	105372093,6563
15.0	1.0E-15	3704	(Decrease of PLT)	Response to hepatitis C treatment	0	ITPA	3.9	DDRGK1 - ITPA	upstream_gene_variant	303 Japanese ancestry cases	65992	rs6139030	0.17	NR_052000.1,NT_011387.9,XM_006723564.2,XM_006723565.2,XM_011529234.1,XM_011529235.1	rs6139030		NT_011387.9:3147087	20	upstream-variant-2KB	0.1098/550	Y	ITPA	[Homo sapiens]	3704
24.69897000433602	2.0E-25	3704	(Change of Hb)	Response to hepatitis C treatment	0	ITPA	25.0	DDRGK1 - ITPA	upstream_gene_variant	303 Japanese ancestry cases	65992	rs6139030	0.83	NR_052000.1,NT_011387.9,XM_006723564.2,XM_006723565.2,XM_011529234.1,XM_011529235.1	rs6139030		NT_011387.9:3147087	20	upstream-variant-2KB	0.1098/550	Y	ITPA	[Homo sapiens]	3704
5.221848749616356	6.0E-6			Psoriasis	0	TSC1	1.09	TSC1	intron_variant	1,359 European ancestry cases, 1,400 European ancestry controls		rs1076160	0.48	NM_000368.3,NM_000368.4,NM_001162426.1,NM_001162427.1,NT_008470.20,XM_005272211.1,XM_006717271.1,XM_011518979.1	rs1076160		NT_008470.20:64680095	9	intron-variant	0.4123/2065	R	TSC1	[Homo sapiens]	7248
5.3979400086720375	4.0E-6		(IGP39)	IgG glycosylation	0	NR	0.1625	AUTS2	intron_variant	2,247 European ancestry individuals		rs11765886	0.665165836680053	NM_001127231.2,NM_001127232.2,NM_015570.3,NT_007933.16,XM_011516010.1,XM_011516011.1,XM_011516012.1,XM_011516013.1,XM_011516014.1,XM_011516015.1	rs11765886		NT_007933.16:7266393	7	intron-variant	0.2869/1437	Y	AUTS2	[Homo sapiens]	26053
5.301029995663981	4.9999999999999996E-6		(IGP40)	IgG glycosylation	0	NR	0.1591	AUTS2	intron_variant	2,247 European ancestry individuals		rs11765886	0.66506290565198	NM_001127231.2,NM_001127232.2,NM_015570.3,NT_007933.16,XM_011516010.1,XM_011516011.1,XM_011516012.1,XM_011516013.1,XM_011516014.1,XM_011516015.1	rs11765886		NT_007933.16:7266393	7	intron-variant	0.2869/1437	Y	AUTS2	[Homo sapiens]	26053
11.522878745280337	3.0E-12		(acetylcarnitine)	Blood metabolite levels	0	SLC22A4	0.018	SLC22A5	non_coding_transcript_exon_variant	7,824 European ancestry individuals		rs274567	0.37	NM_001308122.1,NM_003060.2,NM_003060.3,NT_034772.7,XM_005272055.2,XR_427718.1,XR_948290.1,XR_948291.1	rs274567		NT_034772.7:82268910	5	intron-variant	0.4573/2290	R	SLC22A5	[Homo sapiens]	6584
5.698970004336019	2.0E-6			Radiation response	0	KIAA0319		KIAA0319	3_prime_UTR_variant	93 African American human lymphoblastoid cell lines, 89 European ancestry human lymphoblastoid cell lines, 95 Han Chinese ancestry human lymphoblastoid cell lines		rs16889440	0.18	NM_001168374.1,NM_001168375.1,NM_001168376.1,NM_001168377.1,NM_001252328.1,NM_014809.3,NT_007592.16,XM_006715288.2,XM_011515022.1,XM_011515023.1,XM_011515024.1,XM_011515025.1,XM_011515026.1,XM_011515027.1	rs16889440		NT_007592.16:24484739	6	utr-variant-3-prime	0.1699/851	Y	KIAA0319	[Homo sapiens]	9856
7.0	1.0E-7			Parasitemia in Tripanosoma cruzi seropositivity	0	CCDC15		LOC105369547	upstream_gene_variant	580 Brazilian ancestry individuals		rs4408325	NR	NT_033899.9,XR_948132.1,XR_948133.1,XR_948134.1,XR_948135.1	rs4408325		NT_033899.9:36948783	11	intron-variant	0.1995/999	W	LOC105369547	[Homo sapiens]	105369547
9.0	1.0E-9	105369597	(EA)	Stroke	0	NINJ2, WNK1	1.27	NINJ2 - LOC105369597	downstream_gene_variant	1,164 European ancestry ischemic cases, 380 European ancestry cases, 18,058 European ancestry controls	4815	rs12425791	0.23	NT_009759.17	rs12425791		NT_009759.17:664318	12		0.2216/1110	V		[Homo sapiens]	
8.698970004336019	2.0E-9	105369597	(ischemic stroke, EA)	Stroke	0	NINJ2, WNK1	1.29	NINJ2 - LOC105369597	downstream_gene_variant	1,164 European ancestry ischemic cases, 380 European ancestry cases, 18,058 European ancestry controls	4815	rs12425791	0.23	NT_009759.17	rs12425791		NT_009759.17:664318	12		0.2216/1110	V		[Homo sapiens]	
9.096910013008056	8.0E-10	105369597		Stroke	0	NINJ2, WNK1	1.26	NINJ2 - LOC105369597	downstream_gene_variant	1,164 European ancestry ischemic cases, 380 European ancestry cases, 18,058 European ancestry controls	4815	rs12425791	0.23	NT_009759.17	rs12425791		NT_009759.17:664318	12		0.2216/1110	V		[Homo sapiens]	
9.0	1.0E-9	105369597	(ischemic stroke)	Stroke	0	NINJ2, WNK1	1.29	NINJ2 - LOC105369597	downstream_gene_variant	1,164 European ancestry ischemic cases, 380 European ancestry cases, 18,058 European ancestry controls	4815	rs12425791	0.23	NT_009759.17	rs12425791		NT_009759.17:664318	12		0.2216/1110	V		[Homo sapiens]	
10.0	1.0E-10	640		Systemic lupus erythematosus	0	C8orf13, BLK	1.39	FAM167A - BLK	upstream_gene_variant	1,311 European ancestry cases, 3,340 European ancestry controls	83648	rs13277113	0.23	NT_077531.5	rs13277113		NT_077531.5:3824550	8		0.3576/1791	R		[Homo sapiens]	
7.3979400086720375	4.0E-8	27076		Cotinine glucuronidation	0	TEX101, LYPD3	0.0337	TEX101 - LYPD3	intergenic_variant	437 European ancestry current smoker individuals, 364 African American current smoker individuals, 453 Latino current smoker individuals, 674 Japanese ancestry current smoker individuals, 311 Native Hawaiian ancestry current smoker individuals	83639	rs34705275	NR	NT_011109.17	rs34705275		NT_011109.17:16188699	19		0.2690/1347	M		[Homo sapiens]	
5.096910013008056	8.0E-6			Amyotrophic lateral sclerosis (sporadic)	1	CNTLN				250 Han Chinese ancestry cases, 250 Han Chinese ancestry controls		kgp7684809		NM_014243.2,NT_016354.20,XM_011532421.1,XM_011532422.1	rs7684809		NT_016354.20:13541965	4	intron-variant	0.0351/176	Y	ADAMTS3	[Homo sapiens]	9508
6.0	1.0E-6			Diisocyanate-induced asthma	0	C4orf12, ARHGAP24	34.08	ARHGAP24	intergenic_variant	74 European ancestry cases, 824 European ancestry controls		rs342958	0.001	NT_016354.20,XM_005263263.3	rs342958		NT_016354.20:26438104	4	intron-variant	0.0980/491	R	ARHGAP24	[Homo sapiens]	83478
6.3979400086720375	4.0E-7		(females)	Body mass index	0	SLC24A5	0.484	SLC24A5	missense_variant	2,763 Bangladeshi ancestry females, 2,591 Bangladeshi ancestry males		rs1426654	0.511	NM_205850.2,NP_995322.1,NT_010194.18,XM_011521458.1,XP_011519760.1	rs1426654		NT_010194.18:24857413	15	missense,reference	0.4377/2192	R	SLC24A5	[Homo sapiens]	283652
6.096910013008056	8.0E-7			Body mass index	0	SLC24A5	0.325	SLC24A5	missense_variant	2,763 Bangladeshi ancestry females, 2,591 Bangladeshi ancestry males		rs1426654	0.51	NM_205850.2,NP_995322.1,NT_010194.18,XM_011521458.1,XP_011519760.1	rs1426654		NT_010194.18:24857413	15	missense,reference	0.4377/2192	R	SLC24A5	[Homo sapiens]	283652
6.698970004336019	2.0E-7			Asthma	0	SLC22A5	1.11	SLC22A5	intron_variant	10,365 cases, 16,110 controls		rs2073643	0.45	NM_001308122.1,NM_003060.2,NM_003060.3,NT_034772.7,XM_005272055.2,XM_011543590.1,XR_427718.1,XR_948290.1,XR_948291.1	rs2073643		NT_034772.7:82277789	5	intron-variant	0.3564/1785	Y	SLC22A5	[Homo sapiens]	6584
5.3979400086720375	4.0E-6			Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	0	SLC22A5	0.14	SLC22A5	intron_variant	8,631 European ancestry individuals		rs274557	0.599	NM_001308122.1,NM_003060.2,NM_003060.3,NT_034772.7,XM_005272055.2,XM_011543590.1,XR_427718.1,XR_948290.1,XR_948291.1	rs274557		NT_034772.7:82275705	5	intron-variant	0.4860/2434	R	SLC22A5	[Homo sapiens]	6584
6.698970004336019	2.0E-7		(Conditioned on rs12470505)	Height	0	IHH		ZNF142	intron_variant	133,653 European ancestry individuals		rs10187066	NR	NM_001105537.2,NR_073599.1,NR_073600.1,NT_005403.18,XM_006712730.2,XM_011511784.1,XM_011511785.1,XM_011511786.1,XM_011511787.1,XM_011511788.1,XM_011511789.1	rs10187066		NT_005403.18:124154021	2	intron-variant	0.4826/2417	R	ZNF142	[Homo sapiens]	7701
6.0	1.0E-6			Amyotrophic lateral sclerosis (sporadic)	1	FAM167A				250 Han Chinese ancestry cases, 250 Han Chinese ancestry controls		kgp10355073		NT_007819.18	rs10355073		NT_007819.18:30506474	7		0.0771/386	Y		has merged	
5.522878745280337	3.0E-6	441108		Crohn's disease	0	intergenic	1.55	SLC22A5 - C5orf56	upstream_gene_variant	1,748 European ancestry cases, 2,938 European ancestry controls	6584	rs6596075	0.17	NT_034772.7	rs6596075		NT_034772.7:82296729	5		0.2584/1294	S		[Homo sapiens]	
5.522878745280337	3.0E-6		(men)	Visceral adipose tissue adjusted for BMI	0	PCDHAC1		PCDHAC2, PCDHA3, PCDHAC1, PCDHA10, PCDHA1, PCDHA2, PCDHA8, PCDHA4, PCDHA7, PCDHA13, PCDHA9, PCDHACT, PCDHA12, PCDHA6, PCDHA5, PCDHA11	intron_variant	5,560 European ancestry female individuals, 4,997 European ancestry male individuals		rs31872	0.39	NM_018898.3,NM_018899.5,NM_018900.3,NM_018901.3,NM_018902.4,NM_018903.3,NM_018904.2,NM_018905.2,NM_018906.2,NM_018907.3,NM_018908.2,NM_018909.3,NM_018910.2,NM_018911.2,NM_031411.2,NM_031849.2,NM_031857.1,NM_031860.2,NT_029289.12	rs31872		NT_029289.12:1538978	5	intron-variant	0.2917/1461	Y	PCDHAC2,PCDHAC1,PCDHA13,PCDHA12,PCDHA11,PCDHA10,PCDHA8,PCDHA7,PCDHA6,PCDHA5,PCDHA4,PCDHA3,PCDHA2,PCDHA1,PCDHA9	[Homo sapiens]	56134,56135,56136,56137,56138,56139,56140,56141,56142,56143,56144,56145,56146,56147,9752
5.154901959985743	7.0E-6	105372169	(Allelic)	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	0	CDH7	32.5	LOC105372168 - LOC105372169	intergenic_variant	64 Japanese ancestry cases, 27 Japanese ancestry controls	105372168	rs637644	0.80	NT_010966.15	rs637644		NT_010966.15:44320224	18		0.4539/2273	Y		[Homo sapiens]	
5.221848749616356	6.0E-6	105372169	(Continous Variable)	Cardiac Troponin-T levels	0	CDH7	0.04	LOC105372168 - LOC105372169	intergenic_variant	9,491 European ancestry individuals, up to 2,053 African American individuals	105372168	rs605920	NR	NT_010966.15	rs605920		NT_010966.15:44306476	18		0.3405/1705	S		[Homo sapiens]	
5.221848749616356	6.0E-6	3111	(IGP16)	IgG glycosylation	0	NR	0.2057	BRD2 - HLA-DOA	downstream_gene_variant	2,247 European ancestry individuals	6046	rs3097645	0.873857556055831	NT_007592.16,NT_113891.3,NT_167245.2,NT_167246.2,NT_167248.2,NT_167249.2	rs3097645		NT_007592.16:32925503|NT_113891.3:4397716|NT_167245.2:4229037|NT_167246.2:4404877|NT_167248.2:4179821|NT_167249.2:4434760	6		0.0851/426	S		[Homo sapiens]	
5.301029995663981	4.9999999999999996E-6	3111	(IGP2)	IgG glycosylation	0	NR	0.2092	BRD2 - HLA-DOA	downstream_gene_variant	2,247 European ancestry individuals	6046	rs3097645	0.874157767431399	NT_007592.16,NT_113891.3,NT_167245.2,NT_167246.2,NT_167248.2,NT_167249.2	rs3097645		NT_007592.16:32925503|NT_113891.3:4397716|NT_167245.2:4229037|NT_167246.2:4404877|NT_167248.2:4179821|NT_167249.2:4434760	6		0.0851/426	S		[Homo sapiens]	
5.698970004336019	2.0E-6	3111	(IGP42)	IgG glycosylation	0	NR	0.2151	BRD2 - HLA-DOA	downstream_gene_variant	2,247 European ancestry individuals	6046	rs3097645	0.874270331235955	NT_007592.16,NT_113891.3,NT_167245.2,NT_167246.2,NT_167248.2,NT_167249.2	rs3097645		NT_007592.16:32925503|NT_113891.3:4397716|NT_167245.2:4229037|NT_167246.2:4404877|NT_167248.2:4179821|NT_167249.2:4434760	6		0.0851/426	S		[Homo sapiens]	
5.522878745280337	3.0E-6	3111	(IGP58)	IgG glycosylation	0	NR	0.2131	BRD2 - HLA-DOA	downstream_gene_variant	2,247 European ancestry individuals	6046	rs3097645	0.873514573726542	NT_007592.16,NT_113891.3,NT_167245.2,NT_167246.2,NT_167248.2,NT_167249.2	rs3097645		NT_007592.16:32925503|NT_113891.3:4397716|NT_167245.2:4229037|NT_167246.2:4404877|NT_167248.2:4179821|NT_167249.2:4434760	6		0.0851/426	S		[Homo sapiens]	
5.154901959985743	7.0E-6	3111	(IGP59)	IgG glycosylation	0	NR	0.2057	BRD2 - HLA-DOA	downstream_gene_variant	2,247 European ancestry individuals	6046	rs3097645	0.87438328769575	NT_007592.16,NT_113891.3,NT_167245.2,NT_167246.2,NT_167248.2,NT_167249.2	rs3097645		NT_007592.16:32925503|NT_113891.3:4397716|NT_167245.2:4229037|NT_167246.2:4404877|NT_167248.2:4179821|NT_167249.2:4434760	6		0.0851/426	S		[Homo sapiens]	
5.221848749616356	6.0E-6	3111	(IGP61)	IgG glycosylation	0	NR	0.206	BRD2 - HLA-DOA	downstream_gene_variant	2,247 European ancestry individuals	6046	rs3097645	0.873550828800713	NT_007592.16,NT_113891.3,NT_167245.2,NT_167246.2,NT_167248.2,NT_167249.2	rs3097645		NT_007592.16:32925503|NT_113891.3:4397716|NT_167245.2:4229037|NT_167246.2:4404877|NT_167248.2:4179821|NT_167249.2:4434760	6		0.0851/426	S		[Homo sapiens]	
6.221848749616356	6.0E-7	3111	(IGP65)	IgG glycosylation	0	NR	0.2253	BRD2 - HLA-DOA	downstream_gene_variant	2,247 European ancestry individuals	6046	rs3097645	0.872971129118433	NT_007592.16,NT_113891.3,NT_167245.2,NT_167246.2,NT_167248.2,NT_167249.2	rs3097645		NT_007592.16:32925503|NT_113891.3:4397716|NT_167245.2:4229037|NT_167246.2:4404877|NT_167248.2:4179821|NT_167249.2:4434760	6		0.0851/426	S		[Homo sapiens]	
5.3979400086720375	4.0E-6		(men)	Visceral adipose tissue/subcutaneous adipose tissue ratio	0	CYP2E1		LOC105378575	intron_variant	5,560 European ancestry female individuals, 4,997 European ancestry male individuals		rs1536827	0.07	NT_030059.14,XR_946512.1	rs1536827		NT_030059.14:91799133	10	nc-transcript-variant	0.1961/982	Y	LOC105378575	[Homo sapiens]	105378575
5.154901959985743	7.0E-6			Response to treatment for acute lymphoblastic leukemia	0	LMBRD2	3.23	LMBRD2	intron_variant	356 European ancestry cases, 53 Black cases, 78 cases		rs267759	NR	NM_001007527.1,NT_006576.17,XM_011514162.1	rs267759		NT_006576.17:36127518	5	intron-variant	0.1148/575	R	LMBRD2	[Homo sapiens]	92255
14.698970004336019	2.0E-15			Esophageal cancer	0	RPL6	1.3	HECTD4	intron_variant	2,031 Han Chinese ancestry cases, 2,044 Han Chinese ancestry controls		rs11066280	0.21	NM_001109662.3,NT_029419.13	rs11066280		NT_029419.13:75144727	12	intron-variant	0.0449/225	W	HECTD4	[Homo sapiens]	283450
5.301029995663981	4.9999999999999996E-6			Height	0	IHH	0.05	NHEJ1	intron_variant	19,633 Japanese ancestry individuals		rs16859517	0.39	NM_024782.2,NT_005403.18	rs16859517		NT_005403.18:124588447	2	intron-variant	0.1474/738	Y	NHEJ1	[Homo sapiens]	79840
7.698970004336019	2.0E-8			Height	0	IHH	0.06	NHEJ1	intron_variant	13,665 European ancestry individuals		rs6724465	0.1	NM_024782.2,NT_005403.18	rs6724465		NT_005403.18:124583109	2	intron-variant	0.1080/541	R	NHEJ1	[Homo sapiens]	79840
20.096910013008056	8.0E-21	640		Kawasaki disease	0	FAM167A, BLK	1.85	FAM167A - BLK	intergenic_variant	428 Japanese ancestry cases, 3,379 Japanese ancestry controls	83648	rs2254546	0.72	NT_077531.5	rs2254546		NT_077531.5:3819044	8		0.1597/800	R		[Homo sapiens]	
5.301029995663981	4.9999999999999996E-6			Breast size	0	SLC4A1AP	0.072	GCKR	intron_variant	16,175 European ancestry female individuals		rs780093	0.416	NM_001486.3,NT_022184.16,XM_011532761.1,XM_011532762.1	rs780093		NT_022184.16:11373617	2	intron-variant	0.2915/1460	R	GCKR	[Homo sapiens]	2646
7.698970004336019	2.0E-8	100419458	(EA)	Immune reponse to smallpox (secreted IL-2)	0	AUTS2		LOC105375341 - LOC100419458	intergenic_variant	Up to 512 European ancestry individuals, up to 199 African American individuals	105375341	rs1403155		NT_007933.16	rs1403155		NT_007933.16:6078647	7		0.0597/299	R		[Homo sapiens]	
5.045757490560675	9.0E-6		(FEV1 decline in asthmatics)	Pulmonary function decline	0	intergenic	0.1829	CNTLN	intron_variant	1,441 European ancestry asthma cases, 2,677 European ancestry controls		rs2383024	NR	NM_017738.3,NT_008413.19,XM_005251492.1,XM_006716793.2,XM_011517940.1,XM_011517942.1	rs2383024		NT_008413.19:17477947	9	intron-variant	0.3025/1515	K	CNTLN	[Homo sapiens]	54875
5.096910013008056	8.0E-6		(Ordinal II)	Lewy body disease	0	intergenic	1.1285	CNTLN	intron_variant	up to 3,526 individuals		rs11739210	0.9824	NM_001114395.2,NM_017738.3,NT_008413.19,XM_005251492.1,XM_006716793.2,XM_011517940.1,XM_011517941.1,XM_011517943.1,XR_929281.1,XR_929282.1	rs11739210		NT_008413.19:17273350	9	intron-variant		Y	CNTLN	[Homo sapiens]	54875
14.698970004336019	2.0E-15		(red hair)	Hair color	0	ASIP	0.22	CDK5RAP1	intron_variant	9,126 European ancestry individuals		rs291671	0.10	NM_001278167.1,NM_001278168.1,NM_001278169.1,NM_016082.4,NM_016408.3,NT_011362.11,XM_011528855.1,XM_011528856.1,XM_011528857.1,XM_011528858.1,XM_011528859.1,XM_011528860.1,XR_936548.1	rs291671		NT_011362.11:2311531	20	intron-variant	0.1250/626	R	CDK5RAP1	[Homo sapiens]	51654
15.154901959985743	6.999999999999999E-16			Height	0	SLC22A5	0.029	LOC553103	intron_variant	133,653 European ancestry individuals		rs274546	0.4	NR_110997.1,NT_034772.7	rs274546		NT_034772.7:82254368	5	intron-variant	0.4519/2263	Y	LOC553103	[Homo sapiens]	553103
43.39794000867204	4.0E-44			Ribavirin-induced anemia	0	DDRGK1, ITPA		ITPA	missense_variant	453 Japanese ancestry individuals		rs1127354	NR	NM_001267623.1,NM_033453.3,NM_181493.2,NP_258412.1,NP_852470.1,NR_052000.1,NR_052001.1,NR_052002.1,NT_011387.9,XM_006723564.2,XM_006723565.2,XM_011529234.1,XM_011529235.1,XP_006723627.1,XP_011527536.1,XP_011527537.1	rs1127354		NT_011387.9:3153196	20	intron-variant,missense,nc-transcript-variant,reference	0.0895/448	N	ITPA	[Homo sapiens]	3704
6.221848749616356	6.0E-7			Amyotrophic lateral sclerosis (sporadic)	1	AUTS2				250 Han Chinese ancestry cases, 250 Han Chinese ancestry controls		kgp13465360		NM_027188.3,NP_081464.1,NT_039185.8,XM_011238864.1,XP_011237166.1	rs13465360		NT_039185.8:23236588	1	missense,reference		R	Smyd3	[Mus musculus]	69726
5.221848749616356	6.0E-6	1330	(partial response - SSRI treated - 2 weeks)	Major depressive disorder	0	RASGEF1B	1.7737	LOC105377306 - COX5BP1	intron_variant	Up to 2,256 European ancestry cases	105377306	rs1822818	0.87	NT_016354.20	rs1822818		NT_016354.20:22620062	4		0.1895/949	Y		[Homo sapiens]	
5.522878745280337	3.0E-6			Chronic lymphocytic leukemia	0	NR	1.46	FARP2	missense_variant	1,121 European ancestry cases, 3,745 European ancestry controls		rs757978	0.26	NM_001282983.1,NM_001282984.1,NM_014808.3,NP_001269912.1,NP_001269913.1,NP_055623.1,NT_005403.18,XM_005247050.3,XM_011512233.1,XM_011512234.1,XM_011512235.1,XM_011512236.1,XM_011512237.1,XP_005247107.1,XP_011510535.1,XP_011510536.1,XP_011510537.1,XP_011510538.1,XP_011510539.1	rs757978		NT_005403.18:146935671	2	missense,reference	0.0805/403	D	FARP2	[Homo sapiens]	9855
8.0	1.0E-8	221262	(MCH, AA)	Red blood cell traits	0	CD164	0.2294	LOC100996634 - CCDC162P	intron_variant	Up to 16,485 African American individuals	100996634	rs9386791	0.416	NT_025741.16	rs9386791		NT_025741.16:49057360	6		0.4423/2215	Y		[Homo sapiens]	
39.045757490560675	9.0E-40		(androsterone sulfate + 2 other traits)	Metabolic traits	0	CYP3A4	0.476	TRIM4	3_prime_UTR_variant	2,820 European ancestry individuals		rs17277546	0.045	NM_033017.3,NM_033091.2,NT_007933.16	rs17277546		NT_007933.16:37385169	7	utr-variant-3-prime	0.0170/85	R	TRIM4	[Homo sapiens]	89122
10.096910013008056	8.0E-11			Bladder cancer	0	SLC14A1	1.17	SLC14A1	5_prime_UTR_variant	2,234 European ancestry cases, 41,603 European ancestry controls		rs17674580	0.33	NM_001128588.3,NM_001146036.2,NM_001146037.1,NM_001308278.1,NM_001308279.1,NM_015865.6,NT_010966.15,XM_005258329.1,XM_005258332.1,XM_005258333.1,XM_006722526.2,XM_011526141.1,XM_011526142.1,XM_011526143.1,XM_011526144.1	rs17674580		NT_010966.15:24818740	18	intron-variant,utr-variant-5-prime	0.1759/881	H	SLC14A1	[Homo sapiens]	6563
7.522878745280337	3.0000000000000004E-8			Coffee consumption (cups per day)	0	EFCAB5, SSH2, CCDC55	0.03	EFCAB5	intron_variant	91,462 European ancestry individuals		rs9902453	0.54	NM_001145053.1,NM_198529.3,NR_026738.1,NT_010783.16,XM_011524759.1,XM_011524760.1,XM_011524761.1,XM_011524762.1,XM_011524763.1,XM_011524764.1,XM_011524765.1,XM_011524766.1,XM_011524768.1,XR_934454.1	rs9902453		NT_010783.16:3086097	17	intron-variant	0.4279/2143	R	EFCAB5	[Homo sapiens]	374786
5.096910013008056	8.0E-6	105378349	(Total glutathione )	Obesity-related traits	0	PCBD1	0.03	PCBD1 - LOC105378349	upstream_gene_variant	815 Hispanic children from 263 families	5092	rs1466576	0.472	NT_030059.14	rs1466576		NT_030059.14:29235093	10		0.2692/1348	R		[Homo sapiens]	
6.096910013008056	8.0E-7	9242	(Strict, EA)	Autism	0	intergenic	1.56	LOC105375892 - MSC	intergenic_variant	1,419 European ancestry cases from 1416 families	105375892	rs7834018	NR	NT_008183.20	rs7834018		NT_008183.20:25722242	8		0.2817/1411	Y		[Homo sapiens]	
38.69897000433602	2.0E-39			QT interval	0	NOS1AP	1.46	OLFML2B	intron_variant	Up to 70,389 European ancestry individuals, up to 672 Orcadian individuals		rs6669543	0.258	NM_001297713.1,NM_015441.2,NT_004487.20,XM_005245075.2	rs6669543		NT_004487.20:18826648	1	intron-variant	0.4908/2458	Y	OLFML2B	[Homo sapiens]	25903
19.0	1.0E-19			QT interval	0	NOS1AP	4.73	OLFML2B	intron_variant	Up to 70,389 European ancestry individuals, up to 672 Orcadian individuals		rs4656345	0.085	NM_001297713.1,NM_015441.2,NT_004487.20,XM_005245075.2	rs4656345		NT_004487.20:18836860	1	intron-variant	0.0124/62	R	OLFML2B	[Homo sapiens]	25903
5.096910013008056	8.0E-6	79925		Metabolite levels (HVA/5-HIAA ratio)	0	intergenic	0.2134	PRLR - SPEF2	intergenic_variant	up to 398 European ancestry individuals	5618	rs284737		NT_006576.17	rs284737		NT_006576.17:35451098	5		0.3001/1503	Y		[Homo sapiens]	
37.39794000867204	4.0E-38			Paget's disease	0	OPTN	1.67	OPTN	intron_variant	741 European ancestry cases, 2,699 European ancestry controls		rs1561570	0.53	NM_001008211.1,NM_001008212.1,NM_001008213.1,NM_021980.4,NT_008705.17,XM_005252336.2,XM_005252337.3,XM_005252338.2	rs1561570		NT_008705.17:13103726	10	intron-variant	0.4329/2168	Y	OPTN	[Homo sapiens]	10133
12.221848749616356	6.000000000000001E-13			Paget's disease	0	OPTN	1.54	OPTN	intron_variant	692 European ancestry cases, 1,001 European ancestry controls		rs1561570	0.55	NM_001008211.1,NM_001008212.1,NM_001008213.1,NM_021980.4,NT_008705.17,XM_005252336.2,XM_005252337.3,XM_005252338.2	rs1561570		NT_008705.17:13103726	10	intron-variant	0.4329/2168	Y	OPTN	[Homo sapiens]	10133
5.698970004336019	2.0E-6		(EA, women)	Body mass index	0	KAT8	0.02	KAT8	splice_region_variant	up to 104,666 European ancestry male individuals, up to 132,115 European ancestry female individuals, 370 African American male individuals, 517 African American female individuals, 512 Hispanic male individuals, 764 Hispanic female individuals		rs9925964	0.62	NM_032188.2,NM_182958.2,NT_187260.1,XM_011545969.1,XM_011545970.1,XM_011545971.1	rs9925964		NT_187260.1:12632088	16	intron-variant,utr-variant-5-prime	0.3594/1800	R	KAT8	[Homo sapiens]	84148
9.096910013008056	8.0E-10		(EA)	Body mass index	0	KAT8	0.019	KAT8	splice_region_variant	up to 104,666 European ancestry male individuals, up to 132,115 European ancestry female individuals, 370 African American male individuals, 517 African American female individuals, 512 Hispanic male individuals, 764 Hispanic female individuals		rs9925964	0.62	NM_032188.2,NM_182958.2,NT_187260.1,XM_011545969.1,XM_011545970.1,XM_011545971.1	rs9925964		NT_187260.1:12632088	16	intron-variant,utr-variant-5-prime	0.3594/1800	R	KAT8	[Homo sapiens]	84148
10.045757490560675	9.0E-11			Body mass index	0	KAT8	0.02	KAT8	splice_region_variant	up to 104,666 European ancestry male individuals, up to 132,115 European ancestry female individuals, 370 African American male individuals, 517 African American female individuals, 512 Hispanic male individuals, 764 Hispanic female individuals		rs9925964	0.623	NM_032188.2,NM_182958.2,NT_187260.1,XM_011545969.1,XM_011545970.1,XM_011545971.1	rs9925964		NT_187260.1:12632088	16	intron-variant,utr-variant-5-prime	0.3594/1800	R	KAT8	[Homo sapiens]	84148
